Back to results
CompletedPhase 1

Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors

NCT00003107

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Indiana University Cancer Center

Indianapolis, Indiana, United States

View on ClinicalTrials.gov
Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors — TrialFind